NDC 58005-102 - AMINO ACID
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58005-102
- Package NDCs from labels
- 58005-102-05
- Manufacturer
- Sparhawk Laboratories, Inc.
- Effective date
- 2017-02-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AMINO ACID CONCENTRATE | Sparhawk Laboratories, Inc. | 2017-02-01 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58005-102-05 | AMINO ACID | 500 mL in 1 BOTTLE | CONCENTRATE | 500 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 660YQ98I10 |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | 727be945-df2a-4fbf-ade4-f242e2647976 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | 302b3fa7-ea87-4bf1-aae0-6a2d7459de86 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| SUTAB | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | dddd2701-4d46-44de-a9f8-303d4dcceef7 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Granules India Ltd | 60285a8d-bcb0-40ba-b359-df5c89480cd6 | 2026-10-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Granules India Ltd | 113c031c-6de3-4497-a57d-9740b1ce08ac | 2026-10-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Epsom Salts | MAGNESIUM SULFATE | Jell Pharmaceuticals Pvt. Ltd. | 8d4443ec-fc8b-0119-e053-2a95a90a68f0 | 2026-10-07 | Warnings | SK47B8698T |
| Epsom Salt | MAGNESIUM SULFATE | Walgreens | 7365e199-5038-48eb-b0b9-7b46f9894dd7 | 2026-10-02 | Warnings | SK47B8698T |
| Potassium Chloride | POTASSIUM CHLORIDE | IPG Pharmaceuticals, Inc. | 5dad0879-0f97-4c7d-98fa-baaed51cd2d8 | 2026-10-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Magnesium Sulfate in Water | MAGNESIUM SULFATE | WG Critical Care, LLC | 952000af-f58d-4762-b806-443cbdda0168 | 2026-10-01 | Warnings, Adverse reactions | SK47B8698T |
| Magnesium Sulfate in Dextrose | MAGNESIUM SULFATE | WG Critical Care, LLC | 8da9c33f-e3cd-4026-b034-2b964401b346 | 2026-09-30 | Warnings, Adverse reactions | SK47B8698T |
| Magnesium Sulfate in Water | MAGNESIUM SULFATE | WG Critical Care, LLC | 752f55bb-c4ca-4545-94b3-3deea66888d4 | 2026-09-30 | Warnings, Adverse reactions | SK47B8698T |
| Magnesium Sulfate in Dextrose | MAGNESIUM SULFATE | WG Critical Care, LLC | fc5d7e38-c05c-4219-a4b2-2488a7da044a | 2026-09-30 | Warnings, Adverse reactions | SK47B8698T |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | QUAGEN PHARMACEUTICALS LLC | 8fac192f-48ab-4def-9c3a-f1cd50b3e2b7 | 2026-09-29 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE ORAL | American Health Packaging | 7c8dd5b0-db93-430f-8bf8-0318504f744c | 2026-09-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Epsom Salt | MAGNESIUM SULFATE | United Natural Foods, Inc. dba UNFI | 5b4b4805-a8ff-4efe-94bc-411090ab5f9c | 2026-09-23 | Warnings, Adverse reactions | SK47B8698T |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.